Frontlight ResearchEarly access
Primary biliary cholangitis trials in United States
7 of 11 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleSeladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
- Where
- Atlanta, Baltimore, Bethesda, Birmingham, Boston, Charleston, Chicago, Cleveland, Columbus, Cordova, Dallas, Denison, Detroit, Fairfax, Fort Myers, Hershey, Iowa City, Jefferson, Lancaster, Los Angeles, Louisville, Manhasset, Miami, Milwaukee, New Orleans, Newport News, New York, Pasadena, Philadelphia, Phoenix, Pittsburgh, Portland, Redwood City, Richmond, Rochester, Roseville, Sacramento, San Antonio, San Francisco, Sarasota, Seattle, South San Francisco, Tampa, Winston-Salem
- Age
- 18 years and over
- People
- 402 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06051617 · EU 2024-516525-31-01 - Phase 2Taking peopleStudy of Seladelpar and Cilofexor in Participants With Primary Biliary Cholangitis
- Where
- Atlanta, Colorado Springs, Johnson City, Lakewood Rch
- Age
- 18 years to 75 years
- People
- 132
- Run by
- Gilead Sciences
See details and how to joinNCT07841977 - Phase 3Taking peopleA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
- Where
- Albuquerque, Ann Arbor, Arlington, Aurora, Austin, Charleston, Charlottesville, Colorado Springs, Columbia, Cordova, Coronado, Dallas, Englewood, Fort Worth, Houston, Huntington, Kansas City, Katy, Little Rock, Littleton, Los Angeles, Miami, New York, Pembroke Pines, Pittsburgh, Richmond, Rochester, Sacramento, San Antonio, Seattle, Shreveport, Tampa, Tucson, Waco, Ypsilanti
- Age
- 18 years and over
- People
- 276 worldwide
- Run by
- Ipsen
See details and how to joinNCT06016842 · EU 2023-505251-43-00 - Phase 2Not yet taking people in United StatesNemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
- Where
- Jacksonville
- Age
- 18 years and over
- People
- 15
- Run by
- Mayo Clinic
See details and how to joinNCT07843420 - Phase 3Taking peopleStudy of Saroglitazar Magnesium for PBC Patients With Incomplete Response or Intolerant to UDCA Therapy
- Where
- Lakewood Rch
- Age
- 18 years to 80 years
- People
- 90 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07424677 · EU 2026-526680-38-00 - Phase 1Taking peopleEvaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
- Where
- Indianapolis
- Age
- 18 years to 80 years
- People
- 6
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT06825559 - Phase 3Taking peopleLong-Term Study to Evaluate the Safety and Efficacy in Participants With Primary Biliary Cholangitis of Saroglitazar Magnesium-V on Clinical Outcomes
- Where
- Houston, Indianapolis, Marietta
- Age
- 18 years to 64 years
- People
- 386 worldwide
- Run by
- Zydus Therapeutics Inc.
See details and how to joinNCT07216235 · EU 2025-524067-20-00